The Swiss life sciences industry, despite a challenging dip in job vacancies in 2023 (down by 31.4%), shows a robust rebound in 2024, with vacancies projected to rise by 24.1%. R&D roles have been notably active, reflecting global trends and a renewed push in innovation.
Stay informed with the latest insights on labour market shifts, hiring patterns, and industry-specific analytics. Our Snapshots highlight key developments across multiple sectors, helping you navigate the evolving recruitment landscape.
The UK pharmaceuticals sector is recovering from its post-pandemic slowdown, with a focus on addressing the backlog of drug approvals by the MHRA. As approvals accelerate, pharmaceutical manufacturing is ramping up, contributing to an 8.8% increase in engineering vacancies in 2024 compared to last year.
Congratulations to Suzanne Swan and Kirsty Calow who have recently launched Nexa Life Sciences as Managing Partners and part of the Concilium Search Group.
After a protracted slowdown in the post pandemic period, the life sciences sector is finally springing back to life. July was the record month this year so far and the signs are positive looking forward. In terms of what had caused the lull, it is worth factoring that with the UK leaving the EU this had meant that the MHRA had to take over regulatory approvals for new trials, and this process has taken time to bed in.
